Overview

Treatment Program for Anemia in AIDS Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.
Phase:
N/A
Details
Lead Sponsor:
R W Johnson Pharmaceutical Research Institute
Treatments:
Epoetin Alfa